| abstract |
(57) Summary The present invention relates to the use of prenyltransferase inhibitors for the preparation of a medicament for treating a disease resulting from the pre-nylation of the γ sub-unit of G protein. These diseases include the following biological functions or disorders: olfaction, taste, light perception, neurotransmission, neurodegeneration, endocrine and exocrine gland functions, autocrine and paracrine regulation, arterial tone, embryogenesis, viral infection , Immunological functions, diseases associated with diabetes and obesity. |